BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25558600)

  • 1. [Cytology is in pivotal role at screening and surveillance of PSC].
    Boyd S; Arola J; Mäkisalo H; Färkkilä M
    Duodecim; 2014; 130(22-23):2397-404. PubMed ID: 25558600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
    Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
    Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
    Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
    Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
    Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
    J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
    Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
    Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
    Azeem N; Gostout CJ; Knipschield M; Baron TH
    Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
    Trilianos P; Selaru F; Li Z; Gurakar A
    Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
    Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
    Folseraas T; Boberg KM
    Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.
    Vannas MJ; Boyd S; Färkkilä MA; Arola J; Isoniemi H
    Liver Int; 2017 May; 37(5):735-742. PubMed ID: 28453918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
    von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
    Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.
    Thosani N; Banerjee S
    Clin Liver Dis; 2014 Nov; 18(4):899-911. PubMed ID: 25438290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
    Quinn KP; Tabibian JH; Lindor KD
    Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.
    Moff SL; Kamel IR; Eustace J; Lawler LP; Kantsevoy S; Kalloo AN; Thuluvath PJ
    Gastrointest Endosc; 2006 Aug; 64(2):219-23. PubMed ID: 16860072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.